Alexandria Real Estate Equities, Inc. at the forefront of immediate scaling coVID-19 tests across the life sciences ecosystem

“O.itemList.length” “- this.config.text.ariaShown

“This.config.text.ariaFermé”

PASADENA, California, August 13, 2020 / PRNewswire / – Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban workplace REIT and first owner, THE oldest and pioneering operator and developer focused exclusively on collaboration in life sciences, technology and agricultural technology CAMPUSes at THE AAA Innovation Hubs are at the forefront of the important life science ecosystem that advances responses for COVID-19 through a multifaceted, high-impact strategy that includes a critical purpose of COVID-19 testing to be realized. all Americans. Large-scale screening and diagnostic testing, as well as effective vaccines and therapies, are desperately needed to resolve the global COVID-19 pandemic.

Through the uninterrupted operations of the national real estate platform Labspace®, an indispensable tool in Alexandria, the company has allowed more than 80 of its life sciences tenants to continue the much-needed paints on COVID-like diagnoses, checks, treatments and vaccines. as well as other essential research, development, production and marketing efforts. Abbott Laboratories, Adaptive Biotechnologies, Color, Cue Health, Laboratory Corporation of America Holdings, Mammoth Biosciences, Quest Diagnostics, Quidel, Roche, Thermo Fisher Scientific and Verily Life Sciences are among the many Alexandria tenants who are working tirelessly on the quality, capacity and rotation rate of COVID-19 testing to better determine who has an active infection, who has been exposed to the virus, and who has developed the virus.

The company-wide opinion leaders who make up the COVID-19 management organization in Alexandria have partnered with their COVID-19 advisory committee of esteemed biopharma, clinical studies and psychiatry experts to strategically plan for their tenants to safely bring more workers. back to Alexandria. world-class campuses and properties. Together, the working group and advisory board have implemented a primary national detection initiative for COVID-19 to facilitate the detection of the regime for tenants to identify asymptomatic cases among their workers. Alexandria has introduced the program with centralized sites in Cambridge, south of San Francisco and New York and is also expanding the testing program to other regions.

“It has been very rewarding to work largely with Alexandria and its COVID-19 working group on the company’s complicated technique for COVID-19 detection projects and far-reaching efforts to ensure that their biotech and life science tenants can safely advance vital paints. Michael PelliniArray MD, managing partner of Section 32, a venture capital fund in the fields of technology, physical care and life sciences, said, and a key member of the COVID-19 Advisory Committee in Alexandria. “Improving and scaling effective national and regional diagnostic and detection tests is essential to alleviate the burden of the global COVID-19 pandemic. As the U.S. call soars. For COVID-19 testing, we want to put in place physically powerful, evidence-based employees to provide the actionable and timely data that was desired to safely reopen the U.S. economy.”

In a notable example of Alexandria’s physically powerful infrastructure and its pre-eminent life sciences and health care networks, Alexandria was contacted through the CEOs of its Cambridge-based Cambridge Triplet Therapeutics, Verve Therapeutics and Kymera Therapeutics tenants to provide the mandatory infrastructure for a COVID. 19 visit the site as an additional guarantee for the local life science network to ensure that more workers have access to regime verification. Following the good luck of a pilot detection program backed through this Cambridge-based opinion leaders organization in collaboration with Alexandria Color’s tenant and investment holding company, a fitnesscare generation company and a leader in distributed fitnesscare and clinical control, Alexandria was invited to register for the effort to launch a COVID-19 verification site committed to Alexandria Technology® in Cambridge. Alexandria also collaborated with Color at a tenant verification site in South San Francisco at the Alexandria Technology Center®- Gateway. Both sites are recently reviewing a total of more than 1,000 more people in the week. In New York, Alexandria works with One Medical, a number one care practice based on adhesion, to provide access to COVID-19 controls on the Alexandria Center campus® for Life Science. Alexandria donated and delivered the important infrastructure for those verification sites in record time, and each site was configured with physical distance responses and advanced ventilation to create certain verification environments.

“Our purpose is to enable faster, more accessible, scalable COVID-19 detection and an asymptomatic case regimen as a critical measure to maintain the security of our campuses and communities,” said Whitney Snider, MD, MBA, Director of Science and Technology and Director of Alexandria LaunchLabs® – New York City at Alexandria Real Estate Equities, Inc./Alexandria Venture Investments, as well as a member of the COVID-19 broker group. By building key partnerships with Color, One Medical and others for local testing capability and reducing response times, we hope to make a significant contribution to reducing the spread of COVID-19 in our ecosystems and facilitating a safer reopening of workplaces, schools and communities. and As we look at the prospect of a resurgence this fall, we will continue to compare new technologies that allow immediate detection at the point of attention, such as antigen and saliva-based techniques, and help ensure that our life sciences in communities have access to them. “

In addition, with Alexandria’s reputation for leadership at the forefront of the life sciences ecosystem to advance responses for COVID-19 and human fitness, and the company’s proven ability to provide and highly complex services at a budget time, Alexandria has also been addressed. through some of its existing tenants, Cue Health, to facilitate the expansion of a new production capacity that helps the progression and commercialization of its COVID-19 and influenza A/B controls, among other products. To temporarily meet this vital COVID expansion requirement, Alexandria has actively acquired and rebuilt 9877 Waples Street, 63,774 RSF assets in its Sorrento Mesa submarket in San Diego. The pricing project, which is 100 percent pre-leased to Cue Health, is expected to be first completed in 2021. Cue Health is a next-generation fitnesscare company that has leveraged its connected diagnostic platform for a fast, portable molecular solution. COVID-19 control at the point of service that detects SARS-CoV-2 RNA (the virus that causes COVID-19) in 25 minutes from a nasal pattern taken from the lower component of the nose. In June, Cue Health obtained the FDA’s emergency use authorization to use its COVID-19 control under the supervision of a qualified fitness professional and is seeking more FDA approvals for the use of COVID-19 control in environments such as the workplace, schools and home. The company also completed a $100 million C-Series funding before this year and earned $13 million in investment from the U.S. Advanced Biomedical Research and Development Authority (BARDA), which helped drive the progression of its easy-to-use COVID-19. Test.

About Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an SP 500®, He is the oldest, pioneering owner, operator and developer who focuses only on collaborative life sciences, generation and agriculture campuses in the AAA innovation cluster, with a global market capitalization of $27.7 billion as of June 30, 2020 and an asset base in North America of 43.0 million francs. North America’s asset base includes 28.8 million working RSF buildings and RSF 2.3 million of Class A buildings under construction, RSF 6.6 million of short- and medium-term progression and reproach projects, and 5.3 million square feet of long-term progression projects. Founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations, adding Greater Boston, San Francisco, New York, San Diego, Seattle, Maryland and Triangle Research. Alexandria has a long history and proven in creating Class A homes clustered on urban life sciences, generation and farm technology campuses that provide our state-of-the-art tenants with highly dynamic and collaborative environments that decorate their ability to effectively recruit and retain the world. skill and motivate productivity. efficiency, creativity and success. Alexandria also supplies strategic capital to life sciences, generation and agricultural generation processing companies through our venture capital division. We believe that our exclusive business style and diligent subscription ensure a diverse, high-quality tenant base that translates into higher occupancy levels, longer rental terms, superior rental income, superior returns, and superior long-term asset value. For more information about Alexandria, visit www.are.com.

Forward-looking statements

This press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, but are not limited to, statements relating to the possible effects of the COVID-19 pandemic and the uncertainties that we, our tenants and the global and national economies face as a result, as well as customers of the good luck of any COVID-19 verification methodology, remedy or vaccine. These forward-looking statements are based on Alexandria’s existing intent, ideals, or expectations, but forward-looking statements are not guaranteed and would possibly not occur. Actual effects may differ materially from the content or implied in Alexandria’s forward-looking statements due to a variety of factors. All forward-looking statements are made as of the date of this press release, and Alexandria assumes no legal responsibility to update this information. For more information on hazards and uncertainties that may also cause the actual effects to differ materially from those expected in the Company’s forward-looking statements, as well as hazards and uncertainties similar to the Company’s operations in general, please refer to the documents submitted by the Company with the Securities and Exchange Commission. Array adding its recent maximum annual report on Form 10-K and all quarterly reports submitted later on Form 10-Q.

CONTACT: Sara Kabakoff, Vice President of Corporate Communications, (626) 788-5578, [email protected]

View content: http://www.prnewswire.com/news-releases/alexandria-real-estate-equities-inc-at-the-vanguard-of-the-life-science-ecosystems-rapid-scaling-of-test -covid-19-301111373.html

SOURCE Alexandria Real Estate Equities, Inc.

Leave a Comment

Your email address will not be published. Required fields are marked *